Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

China flag China · Delayed Price · Currency is CNY
6.44
+0.16 (2.55%)
Apr 29, 2026, 3:04 PM CST
97.55%
Market Cap 6.63B
Revenue (ttm) 759.50M
Net Income (ttm) -135.94M
Shares Out 1.06B
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,083,774
Average Volume 81,773,757
Open 6.18
Previous Close 6.28
Day's Range 6.18 - 6.47
52-Week Range 3.20 - 6.67
Beta 0.26
RSI 63.29
Earnings Date Apr 23, 2026

About SHE:300006

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1999
Employees 973
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300006
Full Company Profile

Financial Performance

In 2025, SHE:300006's revenue was 775.69 million, a decrease of -2.50% compared to the previous year's 795.60 million. Losses were -134.71 million, 53.4% more than in 2024.

Financial Statements

News

There is no news available yet.